For instance, around 40% GBM and 80% anaplastic oligoastrocytomas were diagnosed with MGMT promoter methylation while pilocytic astrocytoma and most non-glial brain tumors were mostly negative [13]. This evidence concerns the gene MGMT and glioblastoma.